- Home
- INDO vs CRIS Comparison
INDO vs CRIS Comparison
Compare INDO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDO | CRIS |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | Indonesia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 14.6M |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | INDO | CRIS |
|---|---|---|
| Price | $3.09 | $1.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | ★ 444.0K | 125.1K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,293,625.00 | ★ $11,650,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $2.10 | $0.96 |
| 52 Week High | $7.95 | $4.50 |
Technical Indicators
Market Signals| Indicator | INDO | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 55.63 | 34.05 |
| Support Level | $2.95 | $0.96 |
| Resistance Level | $3.21 | $1.14 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 66.79 | 12.50 |
Price Performance
Historical ComparisonAbout INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.